Cargando…
Syrian hamster as an ideal animal model for evaluation of cancer immunotherapy
Cancer immunotherapy (CIT) has emerged as an exciting new pillar of cancer treatment. Although benefits have been achieved in individual patients, the overall response rate is still not satisfactory. To address this, an ideal preclinical animal model for evaluating CIT is urgently needed. Syrian ham...
Autores principales: | Jia, Yangyang, Wang, Yanru, Dunmall, Louisa S Chard, Lemoine, Nicholas R., Wang, Pengju, Wang, Yaohe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008950/ https://www.ncbi.nlm.nih.gov/pubmed/36923404 http://dx.doi.org/10.3389/fimmu.2023.1126969 |
Ejemplares similares
-
Syrian Hamster as an Animal Model for the Study on Infectious Diseases
por: Miao, Jinxin, et al.
Publicado: (2019) -
Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy
por: Baleeiro, Renato B., et al.
Publicado: (2022) -
Characterization of the Intra-tumoral B Cell Immunoglobulin Repertoire Is of Prognostic Value for Esophageal Squamous Cell Carcinoma
por: Wang, Zhizhong, et al.
Publicado: (2022) -
An effective therapeutic regime for treatment of glioma using oncolytic vaccinia virus expressing IL-21 in combination with immune checkpoint inhibition
por: Sun, Yijie, et al.
Publicado: (2022) -
A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell Carcinoma
por: Zhang, Zifang, et al.
Publicado: (2020)